GlaxoSmithKline starts Phase III study to test combined BRAF/MEK inhibition in patients with BRAF positive melanoma following surgery
1 February 2013 | By GlaxoSmithKline
GSK announced the start of COMBI-AD...
List view / Grid view
News
Obinutuzumab (GA101) significantly improved progression-free survival in people with chronic lymphocytic leukemia (CLL)
31 January 2013 | By Roche
Positive results from stage 1 of CLL11...
BASF completes acquisition of Pronova BioPharma
31 January 2013 | By BASF
BASF has completed the acquisition of Pronova BioPharma ASA, Lysaker, Norway...
Novo Nordisk increased operating profit by 32% in 2012
31 January 2013 | By Novo Nordisk
Sales growth of 18% driven by Victoza®, NovoRapid® and Levemir®...
Catalent Applied Drug Delivery Institute launches 2nd annual Global Academic Competition for Life Sciences Leaders of Tomorrow
30 January 2013 | By Catalent Pharma Solutions
Aim to encourage students...
FDA allows Mycoplasma release testing of a biopharmaceutical product using MycoTOOL®
In November 2012, the US Food and Drug Administration accepted the use of the MycoTOOL® PCR Mycoplasma Detection Kit as a release method for a biopharmaceutical product manufactured by Roche Applied Science intended for distribution in the United States.
Genzyme and Isis announce FDA approval of KYNAMRO™ injection for the treatment of HoFH
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
FDA Advisory Committee recommends approval of olodaterol* for maintenance treatment of COPD
29 January 2013 | By Boehringer Ingelheim
Olodaterol may provide a new treatment option in patients with COPD...
TARGAXAN® 550 (Rifaximin-alpha 550 mg tablets) launched in the UK
28 January 2013 | By Burson-Marsteller
Norgine Pharmaceuticals Limited and Alfa Wassermann are pleased to announce the launch of TARGAXAN® 550 in the UK...
Genzyme’s LEMTRADA™ application for MS accepted for review by the FDA
28 January 2013 | By Sanofi
Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.
Auvi-Q™ is now available in the U.S.
28 January 2013 | By Sanofi
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions...
GSK and Biological E. announce joint venture to develop combination vaccine for India and other developing countries
28 January 2013 | By GlaxoSmithKline
GSK and Biological E. announced an agreement to form a 50/50 joint venture...
Amgen announces results from Phase 3 PAVES Study evaluating Neulasta® in patients with colorectal cancer
26 January 2013 | By Amgen
Results from Pegfilgrastim and Anti-VEGF Evaluation Study...
Pfizer receives FDA approval for the use of Prevnar 13
25 January 2013 | By Pfizer
Prevnar 13 is the first and only pneumococcal conjugate vaccine approved for this age group...
FDA approves OXYTROL® FOR WOMEN
25 January 2013 | By Merck
Merck announced that the U.S. FDA has approved OXYTROL FOR WOMEN, the first and only over-the-counter treatment for overactive bladder in women...
